Your BPC-157 Page Has Four Vial Sizes and Four URLs — Google Only Trusts One, and It's Not the One Selling

Search "BPC-157 5mg vs 10mg dosage" in an incognito window and count how many research-peptide suppliers show up. Now search the compound name alone. If your site ranks for neither — despite having a COA for every batch, a clean age gate, and a checkout that doesn't scream "buy me now" to a payment processor — the problem isn't your compliance work. It's that you built four URLs for one product, and Google can't decide which one is real.

This happens on almost every peptide ecommerce build we audit. A supplier carries BPC-157 in 5mg, 10mg, 15mg, and 20mg vials, sometimes bundled into 3-packs and 5-packs for wholesale buyers. Instead of one page for the compound with a size selector, the platform — usually Shopify or WooCommerce with a variants plugin — spins up a separate product URL for every size. Four vials become four pages. Forty compounds become 160 to 240 near-identical URLs. Each one has its own title tag, its own H1, its own meta description, and roughly 90% identical body copy, because the only thing that changed between "BPC-157 5mg Research Peptide" and "BPC-157 10mg Research Peptide" is a single number.

Google's Duplicate-Content Classifier Doesn't Know You Sell Research Compounds

Google doesn't evaluate your catalog the way a customer does. A customer sees four dosage options and picks one. Google's indexing pipeline sees four pages with a 90%+ textual similarity score, no unique research citations differentiating them, and no signal telling it which page deserves to rank. When that happens, Google doesn't index all four. It picks one — usually whichever got crawled first or has the most inbound links — and tells you about the rest in Search Console with a label most site owners never read closely: "Duplicate, Google chose different canonical than user." That's not a warning. That's Google telling you it overrode your site architecture and picked a page you didn't intend to be primary.

The damage compounds three ways. First, whatever backlink equity your compound earns — a citation from a research forum, a mention in a peptide-comparison roundup — lands on whichever variant URL the linking source happened to find, not necessarily the one Google decided to index. That equity is now trapped on a page Google has demoted. Second, your reviews and on-page trust signals split across variants instead of consolidating on one authoritative page, so no single URL ever accumulates enough signal to outrank a competitor who built this correctly. Third, and most expensive: crawl budget. A catalog of 40 compounds times 5 variants is 200 URLs, and if Google's crawler spends its allotted budget on your site re-checking 200 near-duplicate product pages, it has less budget left to discover your new COA uploads, your new research blog posts, or the compound you just added last month. You're not just losing rankings on existing products. You're slowing how fast Google finds anything new.

Why Ecommerce Platforms Build This Problem Into the Default Setup

This isn't a mistake any developer makes on purpose — it's the default behavior of the platforms most peptide suppliers launch on. Shopify treats size, quantity, and pack-count as "variants" of a single product object, but plenty of stores implement each size as its own product listing instead of a variant group, either because a theme was configured wrong or because a team wanted separate SEO pages for each dosage and didn't realize the tradeoff. WooCommerce is worse by default: attribute-based variations can render as query-string parameters (?attribute_size=10mg) that are technically the same URL but get treated as separate crawlable pages if canonical tags aren't explicitly configured — which they usually aren't, because canonical configuration isn't something most theme installs handle out of the box.

Layer on top of that the self-referencing canonical tag, which almost every ecommerce platform sets automatically: every page tells Google "I am the canonical version of myself." That's correct behavior for genuinely distinct pages. It's exactly the wrong signal when four pages are 90% identical and should be pointing at one master URL. Nobody overrides this default because nobody's auditing canonical tags on a 200-SKU catalog — until organic traffic plateaus and nobody can explain why a compound with genuine search demand and a clean compliance build still doesn't rank.

One Compound, One URL, One Authority Page

The fix isn't complicated, but it requires deciding, deliberately, what the canonical unit of your catalog actually is. It's not the vial size. It's the compound. BPC-157 is one research subject with one body of literature, one dosing conversation, and one COA database behind it — it should have one URL that owns all of that authority, with vial size handled as an in-page selector that changes price and availability without generating a new page or a new set of meta tags.

Structured data does the heavy lifting here. A single Product schema block with hasVariant entries lets you declare all four sizes as offers under one parent product — Google reads this as one authoritative page with multiple purchase options, not four competing pages. Pair that with an AggregateOffer for price range and you've given Google exactly the signal it needs to consolidate ranking authority instead of splitting it. If your platform genuinely requires separate URLs per variant for cart or inventory reasons, the fallback is a hard rel=canonical pointing every size variant back to the master compound page — Google will still crawl the variant URLs, but it'll attribute the ranking value to the one page you designated, not whichever one it happened to find first.

The master compound page itself should do more work than a typical product listing: dosing research summaries, batch-level COA links (each linking to the specific certificate, not a generic PDF folder), and citations to the actual studies your customers are searching for when they type "BPC-157 dosage protocol" instead of "buy BPC-157." That page becomes the thing worth linking to, worth citing, worth ranking — because it's the only page on your site that has all the authority instead of a quarter of it. This is the same architectural principle we build into every compliance-first catalog through our peptide website design process — the COA database, the age-gate logic, and the product catalog all have to be engineered as one coherent system, not three separate plugins bolted onto a theme.

We've seen this consolidation move a supplier from zero page-one rankings across an entire compound line to ranking for both the branded compound name and the long-tail dosage searches within eight weeks — not because anything changed about the product, but because Google finally had one page to trust instead of four to guess between.

The Catalog You Built for Convenience Is the One Costing You the Ranking

Every vial size you turned into a separate URL felt like more SEO surface area at the time — more pages, more chances to rank. It's the opposite. You built four weak signals where one strong one would have won. Run a site: search for your top compound right now and count how many of your own URLs show up competing against each other in the results. If it's more than one, you're not out-ranking a competitor. You're out-ranking yourself, and losing.

If you're not sure whether your catalog architecture is consolidating authority or splitting it across silent duplicates, that's a fifteen-minute audit, not a guessing game — worth a direct conversation before your next product launch adds another forty duplicate URLs to the pile.